Moran Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Sell
29,976
-164,029
-85% -$11.4M 0.06% 318
2025
Q4
$12.9M Buy
194,005
+40,672
+27% +$2.63M 0.39% 78
2025
Q3
$10.3M Buy
153,333
+125,104
+443% +$9.9M 0.31% 100
2025
Q2
$2.46M Buy
+28,229
New +$2.21M 0.08% 266
2024
Q3
Sell
-3,546
Closed -$402K 413
2024
Q2
$402K Buy
3,546
+1,236
+54% +$156K 0.01% 357
2024
Q1
$320K Buy
+2,310
New +$290K 0.01% 370

Other funds holding DXCM

Moran Wealth Management's DXCM Position: Q1 2026 in Review

Moran Wealth Management reduced its DexCom (DXCM) stake by 85% in Q1 2026, selling an estimated $11.4M and leaving 29,976 shares worth $1.88M. The position accounts for 0.06% of the portfolio, ranked #318.

Moran Wealth Management first reported a position in DXCM in Q1 2024 and has held it in 6 quarters since. The position peaked at $12.9M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Moran Wealth Management held 29,976 shares of DexCom worth $1.88M as of Q1 2026.
  • Moran Wealth Management sold 164,029 DexCom shares in Q1 2026, an estimated $11.4M.
  • DexCom made up 0.06% of Moran Wealth Management's portfolio in Q1 2026, its #318 holding.
  • Moran Wealth Management first reported a position in DexCom in Q1 2024 and has held it in 6 quarters since.
  • Moran Wealth Management's DexCom position peaked at $12.9M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.